Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients
托珠单抗安全且耐受性良好，可降低 ALS 患者血浆和脑脊液中的 C 反应蛋白浓度
期刊:Muscle & Nerve
影响因子:2.8
doi:10.1002/mus.27339
Carol Milligan, Nazem Atassi, Suma Babu, Richard J Barohn, James B Caress, Merit E Cudkowicz, Armineuza Evora, Gregory A Hawkins, Marlena Wosiski-Kuhn, Eric A Macklin, Jeremy M Shefner, Zachary Simmons, Robert P Bowser, Shafeeq S Ladha
